Clinical trial
IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone…
NCT00368173 · Insmed Incorporated, Industry · Completed
Key facts
| NCT number | NCT00368173 |
|---|---|
| Title | IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome |
| Lead sponsor | Insmed Incorporated, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome |
| Intervention type | Drug |
| Interventions | rhIGF-I/rhIGFBP-3 |
| First posted | Aug 24, 2006 |
| Last update posted | Sep 13, 2012 |
| Countries | Argentina, Australia, Brazil, China, Egypt, Germany, Israel, Italy, Norway, Peru, Slovakia, Turkey (Türkiye) and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: